In rats, the respective contribution of the thyroid and peripheral tissues to the pool ofT3 remains unclear. Most, if not all, of the circulating T3 produced by extrathyroidal sources is generated by 5'-deiodination of T4, catalyzed by the selenoenzyme, type I iodothyronine 5'-deiodinase (5'D-I). 5'D-I in the liver and kidney is almost completely lost in selenium deficiency, resulting in a marked decrease in T4 deiodination and an increase in circulating T4 levels. Surprisingly, circulating T3 levels are only marginally decreased by selenium deficiency. In this study, we used selenium deficiency and thyroidectomy to determine the relative contribution ofthyroidal and extrathyroidal sources to the total body pool of T3. Despite maintaining normal serum T4 concentrations in thyroidectomized rats by T4 replacement, serum T3 concentrations remained 55% lower than those seen in intact rats. In intact rats, restricting selenium intake had no effect on circulating T3 concentrations. Decreasing 5D-1I activity in the liver and kidney by > 90% by restricting selenium intake resulted in a further 20% decrease in serum T3 concentrations in the thyroidectomized, T4 replaced rats, suggesting that peripheral T4 to T3 conversion in these tissues generates approximately 20% of the circulating T3 concentrations. While dietary selenium restriction markedly decreased intrahepatic selenium content (> 95%), intrathyroidal selenium content decreased by only 27%. Further, thyroid 5D-1I activity actually increased 25% in the selenium deficient rats, suggesting the continued synthesis of this selenoenzyme over selenoproteins in other tissues in selenium deficiency. These data demonstrate that the thyroid is the major source of T3 in the rat and suggest that intrathyroidal T4 to T3 conversion may account for most of the T3 released by the thyroid. (J. Clin.
Introduction
In mammals, the relative contribution of thyroidal and extrathyroidal sources to the total body pool ofthe metabolically Part of this work has been presented as an abstract at the 20th meeting of the European Thyroid Association, Dublin, Ireland, [20] [21] [22] [23] [24] [25] active iodothyronine, 3,5,3'-triiodothyronine (T3), is unclear. T3 can be derived from conversion ofthe prohormone thyroxine (T4) by outer ring (5'-) deiodination in the peripheral tissues, by T4 to T3 conversion within the thyroid gland, and by direct secretion ofde novo synthesized thyroidal T3. Estimates ofthe contribution ofextrathyroidal T4 to T3 conversion to the total T3 pool vary from 20% to 100% in the rat (1) (2) (3) and the thyroid accounts for the remainder of the T3 produced daily. Laurberg used in situ thyroid perfusion to directly examine the contribution of the thyroid to the T3 pool and reported that intrathyroidal T4 to T3 conversion accounted for a considerable portion of the T3 secreted from the dog thyroid (4, 5) . Thus, both extrathyroidal and intrathyroidal T4 to T3 conversion appear to participate in the daily production of T3.
T4 to T3 conversion is catalyzed by the enzyme, iodothyronine 5'-deiodinase. Two isozymes ofiodothyronine 5'-deiodinase have been identified. The most abundant form, type I iodothyronine 5'-deiodinase (5D-I), is found in liver, kidney, and thyroid (6) and contains the rare amino acid selenocysteine (7) (8) (9) . Tissue content of 5 D-I in the liver and kidney is proportional to selenium intake (10) . The other isozyme, type II iodothyronine 5'deiodinase (5D-IT), is abundant in the brain, pituitary, and brown adipose tissue and does not contain selenium (11, 12) . T3 generated by 5 DI is released into the general circulation, while the majority of the T3 produced by 5D-1I remains with the cell. The ability to manipulate 5'D-I levels by altering the dietary intake of selenium provides the means to examine the contribution of S'D-I to total T3 production. Selenium deficiency leads to an almost complete loss of 5D-I in the liver and kidney and a 40-50% increase in the serum T4 concentration ( 10, (12) (13) (14) . This increment in circulating T4 is completely accounted for by the prolonged metabolic half-life ofthe iodothyronine due to the loss of5'D-I ( 14) . Paradoxically, serum T3 concentrations are not reciprocally affected and decrease by no more than 20%, if at all (12) (13) (14) . While serum T3 concentrations are marginally depressed by selenium deficiency, circulating T3 sulfate concentrations increase nearly twofold ( 12, 14) . Serum TSH levels remain near normal despite the elevated circulating T4 in the selenium-deficient animal (12) (13) (14) . Thus, despite the marked decrease in hepatic and renal T4 to T3 conversion in the absence of selenium, other sources of T3 appear to be made available in animals lacking 5D-I.
There are several possibilities to account for the discordance between the near complete loss of 5D-I and the marginal fall in circulating T3 observed in selenium deficiency. They include (a) diminished T3 clearance, (b) increased thyroidal 13 secretion, and/or (c) enhanced recovery of T3 from sulfo-conjugates released into the gut in the enterohepatic cycle. Previous work has shown that T3 clearance is only marginally decreased by selenium deficiency and that the 20-25% increase in the metabolic half-life ofthis iodothyronine is insuffi-cient to maintain the steady-state levels of T3 observed in serum ( 14) . The contribution of the thyroid to the T3 pool in the selenium-deficient rat remains to be determined. Likewise, the contribution of enterohepatic recycling of T3 or its conjugates to the circulating T3 pool is unclear.
In this study, we determined the source(s) ofcirculating T3 in selenium-deficient rats. The data show that the thyroid gland serves as a major source of circulating T3 in the rat and suggest that intrathyroidal T4 to T3 conversion accounts for much of the T3 secreted by the thyroid.
Methods
Animals and reagents. Weanling male Sprague-Dawley rats (40-50 g) supplied by Charles River Laboratories (Wilmington, MA) were used in all experiments. The study was approved by the Animal Research Committee and complies with the institutional assurance certificate of the University of Massachusetts Medical Center. Rats were fed a torula yeast based semisynthetic diet (Teklad Premier Laboratory Diets, Madison, WI) for 5 wk. The selenium-deficient diet (TD 86298) contains less than 16 ,gg/kg selenium and the selenium-replete diet (ID 91259)
is the same base diet supplemented with 200 ug/kg selenium as Na2SeO3. Rats were housed in stainless steel cages, and distilled water was available ad lib. Body weight (BW)' was monitored biweekly.
Analyticalprocedures and hormone assays. In all experiments, animals were killed by decapitation and exsanguinated, except where noted. Liver was homogenized in 4 vol (wt/vol) of 20 mM potassium phosphate buffer (pH 7.4), 150 mM NaCl, and in 4 vol (wt/vol) of250 mM sucrose, 20 mM Hepes buffer (pH 7.0), 1 mM EDTA, and 1 mM DTT and stored at -20°C for determination ofglutathione peroxidase activity (GPx) and 5D-I activity, respectively. Thyroid glands were weighed and homogenized in 800 Ml of250 mM sucrose, 20 mM Hepes buffer (pH 7.0), 1 mM EDTA, and 1 mM DTT for determination of 5'D-I activity.
The degree ofselenium deficiency in the rats was determined by the decrease in hepatic GPx activity. GPx activity was determined from the oxidation of NADPH in the presence of 0.35 mM t-butyl hydroperoxide monitored spectrophotometrically at 340 nm ( 15) . Samples were run in duplicate and results were expressed as nmol NADPH oxidized/ min per mg protein. Hepatic GPx activities in intact, selenium-replete and thyroidectomized, T4 replaced, selenium-replete rats were 598±58 nmol NADPH oxidized/ min per mg protein (n = 9) and 906±53 nmol NADPH oxidized/min per mg protein (n = 12), respectively. Type I iodothyronine 5'-deiodinase activity was determined by the release of radioiodide from 10 MM [ '25I] rT3 in the presence of 20 mM DTT (5'D-I) (16) . Samples were run in duplicate and results were expressed as units/mg protein; 1 unit of 5'D-I enzyme activity represents the release of 1 pmol radioiodine/min per mg protein at 37°C. Hepatic type I iodothyronine 5'-deiodinase activities in intact, selenium-replete and thyroidectomized, T4 replaced, selenium-replete rats were 224±15 U/mg protein (n = 12) and 114±8 U/mg protein (n = 9), respectively. Serum TSH was measured in duplicate by RIA using materials obtained from the National Pituitary Agency, National Institutes of Health (Bethesda, MD). Serum T4 and T3 concentrations were determined in duplicate by species-adapted specific RIAs.
Selenium was quantified by measuring the 162 KeV gamma ray produced during the decay of radioactive "mSe after irradiation ofthe sample at a neutron flux. The sensitivity was 0.05 ppm (Research Reactor Facility, University of Missouri-Columbia, Columbia, MO) ( 17). Protein was measured by the method of Bradford ( 18).
1. Abbreviations used in this paper: BW, body weight; GPx, glutathione peroxidase activity.
Experimental procedures
Effect ofaltered selenium intake on serum T4, T3, and TSH concentrations in T4 replaced, thyroidectomized rats. 35 rats (22 selenium supplemented and 13 selenium deficient) were used in this experiment. 3 wk before being killed, 12 selenium-supplemented and 6 selenium-deficient rats were anesthetized using 7 mg ketamine and 0.6 mg xylazine/ 100 g BW and the thyroid glands removed. T4 replacement was begun one day after thyroidectomy by daily intraperitoneal injections of T4 ( 1.1 g/ 100 g BW) for 2 wk. For the final 7 d of the experiment, serum T4 concentrations were maintained at euthyroid levels by the use of an osmotic minipump (Alzet 2001; Alza Corp., Palo Alto, CA) calculated to deliver T4 at a rate of 1.1 ug/ 100 g BW per day. T4 (Sigma Chemical Co., St. Louis, MO) used for hormone replacement was > 99.7% pure as measured by HPLC. Effect of selenium deficiency on the selenium content and 5D-I activity in the thyroid gland. 15 rats (8 selenium supplemented, and 7 selenium deficient) were anesthetized as described above and perfused through the aorta with 40 ml of ice-cold saline. The exsanguinated thyroid gland and liver were removed and frozen at -70'C for subsequent determination of selenium content by neutron activation analysis. In a parallel experiment, thyroidal and liver 5'D-I activities were determined in 10 selenium-supplemented and 10 selenium-deficient rats.
Effects of selenium deficiency on intrathyroidal metabolism of 13 1. Intrathyroidal metabolism of 13'I was determined in groups of 5 rats (5 selenium supplemented and 5 selenium deficient). Animals were killed 2 h after the intraperitoneal injection of 10 MC Na 31I ( 16.2 Ci/,Mg).
Thyroid glands were then dissected free of connective tissue and homogenized in 500 ,l of sodium barbital buffer (pH 8.6) containing 20 mM methimazole and 4 mM KI. The percent uptake of radioiodide and the distribution of the 1311 between MIT, DIT, T3, and T4 was determined by descending paper chromatography after pronase digestion of thyroidal homogenates according to Vagenakis et al. ( 19) .
Statistics
The results are presented as mean±SE. Statistical significance (P < 0.05) was determined using the Student's t test for unpaired values.
Results
Effects ofselenium status on serum T4, T3, and TSH concentrations in T4 replaced, thyroidectomized rats. During the 5-wk experimental period, body weights increased from 55 to 330 g in the euthyroid rats (intact) (n = 17) and from 55 to 289 g in the thyroidectomized rats replaced with T4 (14 replaced) (n = 18), indicating that hormone replacement was almost complete in the thyroidectomized animals. No differences in growth were observed between the selenium-deficient and selenium-supplemented rats. Selenium deficiency resulted in a 97% decrease in hepatic GPx activity and a parallel 93% decrease in hepatic 5'D-I activity in both the intact and T4-replaced rats indicating that the animals were selenium deficient. As shown in Fig. 1 , in selenium-supplemented rats, serum T4 concentrations were similar in the intact and T4 replaced groups (A). Selenium deficiency resulted in the expected increase in the serum T4 concentrations in both the intact and T4 replaced groups (P < 0.05, A vs. B).
Although the serum T4 concentrations were identical in the selenium-supplemented intact and T4 replaced rats, serum T3 concentrations were not normalized and T3 concentrations in the T4 replaced rats remained 55% lower than those in the intact group (Fig. 1 C) . Selenium deficiency did not significantly affect serum T3 values in the intact rats ( 1.23 nM±O. Effect of selenium and thyroidectomy on serum concentrations of T4, T3, and TSH in the rat. Rats were fed a defined diet, thyroidectomized, and replaced with T4 as described in Experimental procedures. Blood was obtained at the time of killing and analyzed for T4, T3, and TSH. Intact, nonthyroidectomized rats; T4 replaced, rats thyroidectomized and replaced with exogenous T4. *P < 0.05. rats, respectively) but decreased the serum T3 concentrations by 20% in the T4 replaced group (C and D) (0.55±0.03 nM vs. 0.44±0.02 nM, P < 0.05 selenium-supplemented vs. seleniumdeficient rats, respectively). In both selenium-supplemented and selenium-deficient thyroidectomized rats, T4 replacement did not normalize the serum TSH concentrations, and they remained 2 to 3 times higher than those observed in the intact rats (Fig. 1, E and F) . Selenium deficiency did not affect serum TSH concentrations in the intact rats.
Effect ofselenium deficiency on selenium content and S'D-I activity in the thyroid. The failure ofT4 replacement to normalize serum T3 concentrations in the selenium-supplemented rats, despite the availability of normal T4 levels to the 5D-I containing tissues, suggested that the thyroid gland may contribute up to 55% of the T3 found in the circulation. Similarly, the thyroid appeared to contribute as much as 60% ofthe circulating T3 in the selenium-deficient rats, animals that lack the selenoprotein 5SD-I in the liver and kidney. Since earlier work suggested that intrathyroidal T4 to T3 conversion was a major contributor to the T3 found in the dog thyroid effluent (4, 5), and thyroidal 59D-I appears to be a selenoprotein (7), the near normal serum T3 concentrations found in intact, selenium-deficient animals raised the possibility that thyroidal 5D-I was unaffected by selenium deficiency. Thus, we determined the effects of selenium deficiency on thyroidal selenium content ( Fig. 2 ) and on 5 D-I activity in the thyroid (Fig. 3) . Rats fed the selenium-deficient diet had a > 97% fall in selenium content in the liver and a corresponding > 93% decrease in liver 5D-I activity. However, in the thyroid, the selenium-deficient diet resulted in only a modest 27% decrease in selenium content, and paradoxically, the 5 D-I activity was increased by 25% (P < 0.05).
Effects ofselenium deficiency on intrathyroidal metabolism of"' I. To evaluate the influence ofaltered selenium intake on intrathyroidal iodine metabolism, we determined the effects of selenium deficiency on the thyroid gland's ability to concentrate and organify iodine. Thyroidal uptake of "'lI was unaffected by selenium intake, and there were no differences in the synthesis of the 13'1-labeled iodotyrosines (MIT and DIT) or iodothyronines (T4 and T3) between selenium-deficient and selenium-supplemented rats (Table I ).
Discussion
Controversy surrounds the contribution of the various tissues to T3 production in the rat. DiStefano (1) estimated that 47% of T3 originates from both thyroidal secretion and extrathyroidal T4 to T3 conversion in liver and kidney, while the remain- Intrathyroidal metabolism of '1'I was determined in 5 selenium-supplemented (Se+) and 5 selenium-deficient (Se-) rats as described in Experimental procedures. Results are expressed as mean±SE.
ing 53% comes from T4 to T3 conversion in the slowly equilibrating pools, such as brain, skin, and muscle. Kinlaw et al. (3) revised their earlier estimate that only 20% ofT3is produced by extrathyroidal T4 to T3 conversion in the rat (2) and suggested that essentially all T3 is produced by T4 to T3 conversion. They also speculated that there is little or no direct secretion ofT3 by the thyroid.
The current data demonstrate that at least 55% of circulating T3 comes from the thyroid gland in the intact, seleniumsupplemented rat. Since liver and kidney 5 D-I still contribute to the pool of circulating T3 in these rats, it is difficult to estimate the relative contribution of the thyroid to total body T3 concentrations. Moreover, the failure ofT4 replacement to normalize serum T3 concentrations in thyroidectomized rats, resulting in reduced liver 5'D-I activity, further complicates the analysis of the sources of circulating T3. However, in the selenium-deficient rat, liver and kidney 5'D-I are virtually absent ( 12) , and the contribution of the thyroid to the serum T3 pool can be approximated. The contribution ofthyroidal T3 derived from thyroglobulin and that from thyroidal T4 to T3 conversion to the circulating T3 pool in these animals, as estimated from the data presented in Fig. 1 panel D, is approximately 65% and the residual serum T3 concentrations present in these rats lacking both the thyroid and extrathyroid 5'D-I is in excellent agreement with previously measured values ( 12) . The source ofthe residual T3 in the serum ofthyroidectomized rats with essentially undetectable serum T4 concentrations and no hepatic and renal 5'D-I remains unclear. Taken together, extrathyroidal T4 to T3 conversion contributes 20-25%, and thyroidal T4 to T3 conversion and T3 derived from thyroglobulin contributes 55-65% of the total body pool of T3. Thus, nearly all the circulating T3 derived from T4 appears to be produced by the selenoenzyme, 5'D-I.
Thyroidectomy resulted in a marked increase in serum TSH concentrations in both selenium-supplemented and selenium-deficient rats despite the maintenance of serum T4 concentrations identical to those observed in the respective intact groups. The presence of increased serum TSH concentrations, decreased serum T3 concentrations, and normal or elevated serum T4 concentrations indicates that circulating T3 plays an important role in regulating TSH secretion ( 12, 20, 21 ) . Previously, we found a modest increase in serum TSH concentrations ( 12) in selenium-deficient rats that was proportional to the fall in circulating T3 suggesting that TSH levels may actu-ally be slightly elevated for some period during dietary restriction of selenium.
Dietary restriction of selenium intake had only a marginal effect on the selenium content and levels of the selenoenzyme 5'D-I in the thyroid gland. Thus, while there was a near complete loss in hepatic selenium content and 5DI activity, the thyroid preserves its selenium stores and 5D-I activity was increased by 25% in selenium-deficient rats. This increase in thyroidal 5D-I may be due to TSH mediated stimulation of 5'D-I activity (22, 23) resulting from small increases in circulating TSH that may occur in selenium-deficient rats. Thus, despite the loss of extrathyroidal T4 to T3 conversion, the thyroid retains the ability to catalyze the 5'deiodination of T4.
Similar preservation of thyroidal selenium stores was recently observed in rats fed a selenium-deficient diet for two generations. Behne and co-workers have observed that the thyroid gland and brain exhibited the highest avidity for selenium (24) . Arthur et al. (25) recently found that thyroidal GPx activity fell by 50% after 5 wk of selenium deficiency. Since the 25% increase in thyroidal 5D-I occurred during this same time period in our studies, these data suggest that the thyroid is resistant to the effects ofselenium deficiency and that thyroidal 5'D-I is preserved over other selenoproteins in selenium-deficient animals. The thyroid is not unique in this regard since the testis and brain also preferentially preserve selenium over other organs (26) .
In this study, intrathyroidal iodine metabolism was also unaffected by selenium deficiency, whereas inconsistent results have been reported on the effects of selenium deficiency on intrathyroidal metabolism by others. Goldstein et al. observed a decrease in PB 13"I after in vitro incubation of thyroid glands from selenium-deficient rats with 131I (27) . Arthur et al. (25) found a decrease in both T4 and T3 content in the thyroid gland from selenium-deficient rats, while Meinhold et al. (28) found no change in T4 and T3 content in the thyroid from rats fed a selenium-deficient diet. Taken together, these data suggest that secretion of de novo synthesized T3 is unaffected by selenium deficiency. It is generally assumed that 70-80% ofthe circulating T3 concentrations (29, 30) is derived from T4 to T3 conversion in human and similar, albeit, more variable estimates have been made for the rat and that the liver, kidney, and thyroid contain nearly all the 5D-I activity in the body (6, 30) . Since extrathyroidal 5'D-I contributes 10-25% ofthe T3 production (see above), then more than 50% of the T3 in the thyroidal effluent is likely to be derived from intrathyroidal T4 to T3 conversion of T4 liberated from thyroglobulin.
The finding that the majority of T3 in the rat derives from the thyroid provides a potential explanation for the apparent discordance between the observed Km of 5 D-I and the concentration of T4 available to extrathyroidal tissues. In vitro estimates ofthe Km forT4 for 5D-I range between 0.5 and 1 IM (6, 30) , while the T4 available to the tissues ("free hormone") is 3-4 orders of magnitude less, indicating that catalysis by 5'D-I in peripheral tissues is very inefficient. However, intracellular T4 levels in the thyroid would be expected to be much greater than those in the circulation, and the Km for T4 of 5D-I may reflect the substrate available in the thyroid rather than that in the circulation.
In conclusion, the current study demonstrates that the thyroid gland is a major source of circulating T3 in rats, accounting for approximately 55% of total T3 production. The contri-bution ofintrathyroidal T4 to T3 conversion to T3 homeostasis appears to be important, but the exact contribution remains to be determined.
